As deficiency deepens, it becomes more persistent
Proposed Mechanisms of Action Research suggests BPC-157 may influence tissue repair through several pathways: Angiogenesis Promotion: Upregulation of vascular endothelial growth factor (VEGF) expression in preclinical studies Enhanced blood vessel formation in wound healing models Improved blood flow to injured tissues, potentially supporting nutrient delivery Interaction with the nitric oxide (NO) pathway affecting vasodilation Growth Factor Modulation: Potential influence on fibroblast growth factor (FGF) signaling Modulation of growth hormone receptor expression in some studies Effects on collagen synthesis and extracellular matrix remodeling Anti-inflammatory Properties: Observed reduction in inflammatory markers in animal models Potential modulation of cytokine profiles Effects on neutrophil and macrophage activity in tissue injury models Mechanistically, these effects are thought to converge on the vascular and connective-tissue repair response
Find a physician who can engage with the science on its actual terms
Current preclinical research on BPC-157 has actually shown protective effects on liver tissue rather than damage, particularly in models of ischemia-reperfusion injury
In LPS-treated rats, cyclooxygenase-2 inhibition can prevent blood pressure elevation, suggesting that LPS-induced inflammation contributes to the hypertensive effect [216]
Below is an overview of our featured peptides, with links to their individual service pages for a deeper dive
